EP 1235841 A1 20020904 - INDUCING CELLULAR IMMUNE RESPONSES TO MAGE2/3 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
Title (en)
INDUCING CELLULAR IMMUNE RESPONSES TO MAGE2/3 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
Title (de)
INDUZIERUNG VON ZELLULÄRER IMMUNANTWORT AUF MAGE2/3 MIT HILFE VON PEPTID- UND NUKLEINSÄUREZUBEREITUNGEN
Title (fr)
DECLENCHEMENT DE REPONSES IMMUNITAIRES CELLULAIRES A MAGE2/3 AU MOYEN DE COMPOSITIONS DE PEPTIDES ET D'ACIDES NUCLEIQUES
Publication
Application
Priority
- US 0033545 W 20001211
- US 45829899 A 19991210
Abstract (en)
[origin: WO0142267A1] The invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare MAGE2/3 epitopes, and to develop epitope-based vaccines directed towards MAGE2/3-bearing tumors. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of cancer.
IPC 1-7
C07H 21/02; C07H 21/04; C07H 21/00; A61K 38/04; A61K 35/08; A61K 38/10; A61K 38/16; A61K 39/00; A61K 48/00; C07K 9/00; C07K 7/00; C07K 11/00
IPC 8 full level
C12N 15/09 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01)
CPC (source: EP US)
A61K 39/001186 (2018.07 - US); A61K 39/4615 (2023.05 - EP); A61K 39/4622 (2023.05 - EP); A61K 39/464486 (2023.05 - EP); A61P 35/00 (2017.12 - EP); A61P 37/04 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 14/4748 (2013.01 - EP); A61K 2039/53 (2013.01 - EP); A61K 2039/6031 (2013.01 - EP); C07K 2319/00 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0142267 A1 20010614; AU 2085001 A 20010618; CA 2393339 A1 20010614; EP 1235841 A1 20020904; EP 1235841 A4 20060412; JP 2003517310 A 20030527
DOCDB simple family (application)
US 0033545 W 20001211; AU 2085001 A 20001211; CA 2393339 A 20001211; EP 00984183 A 20001211; JP 2001543564 A 20001211